2020
DOI: 10.1371/journal.pone.0241166
|View full text |Cite
|
Sign up to set email alerts
|

Assessing COVID-19 risk, vulnerability and infection prevalence in communities

Abstract: Background The spread of coronavirus in the United States with nearly five and half million confirmed cases and over 170,000 deaths has strained public health and health care systems. While many have focused on clinical outcomes, less attention has been paid to vulnerability and risk of infection. In this study, we developed a planning tool that examines factors that affect vulnerability to COVID-19. Methods Across 46 variables, we defined five broad categories: 1) acce… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
19
0
1

Year Published

2020
2020
2022
2022

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(21 citation statements)
references
References 34 publications
(33 reference statements)
1
19
0
1
Order By: Relevance
“…Another study [18], with a similar objective to this study, developing a planning tool that compares the estimated general vulnerability, with confirmed cases of COVID-19 reported in The countries vulnerabilities with high exposure risk to COVID-19 were identified based on each indicator measurement (ranging from 0 (bad) to 1 (good)). Among the advantages of our study, we can say that it is not a probability, but a risk of real exposure.…”
Section: Added Value Of This Studymentioning
confidence: 88%
See 1 more Smart Citation
“…Another study [18], with a similar objective to this study, developing a planning tool that compares the estimated general vulnerability, with confirmed cases of COVID-19 reported in The countries vulnerabilities with high exposure risk to COVID-19 were identified based on each indicator measurement (ranging from 0 (bad) to 1 (good)). Among the advantages of our study, we can say that it is not a probability, but a risk of real exposure.…”
Section: Added Value Of This Studymentioning
confidence: 88%
“…Another study [ 18 ], with a similar objective to this study, developing a planning tool that compares the estimated general vulnerability, with confirmed cases of COVID-19 reported in real-time. The vulnerability considered new variables (indicators) grouped into categories (factors), as in the reference articles cited in the introduction, but using estimates to replace missing data from various sectors, at the county (local) level.…”
Section: Discussionmentioning
confidence: 99%
“…Another study [18], with a similar objective to this study, developing a planning tool that compares the estimated general vulnerability, with confirmed cases of COVID-19 reported in The countries vulnerabilities with high exposure risk to COVID-19 were identified based on each indicator measurement (ranging from 0 (bad) to 1 (good)). https://doi.org/10.1371/journal.pone.0248075.t002…”
Section: Added Value Of This Studymentioning
confidence: 88%
“…COVID-19 severity is higher in those countries where there is already an aging population, with higher risk and requirement of hospilization [Sen, K., 2020]. In New York, 10 percent of total population and 16 percent of senior population are vulnerable and at highest risk of COVID-19 [Kiaghad et al, 2020] and similar results from present study indicates that the household with older people and males are at higher risk of developing a chronic morbidity and hence are at increased risk of severe COVID-19 disease. Other studies have also shown that more males have been reported to have COVID-19 and majority among the deceased (73%: Lake M 2020, Zheng Zet al, 2020).…”
Section: Discussionmentioning
confidence: 99%
“…Other comorbidities that are highly associated with COVID-19 are cancers, strokes and, respiratory infections including asthma and chronic obstructive pulmonary disease (COPD) (Singh AK et al, 2020; Zheng Z et al, 2020; Clark A et al, 2020; Kunal S et al, 2020; Lake M. A. 2020; Kiaghadi, A et al, 2020; Yao Q et al 2020). According to global estimates, most of the mortality due to COVID-19 attributed to either one or more comorbidities (Fang et al, 2020; Leung et al, 2020).…”
Section: Introductionmentioning
confidence: 99%